| 摘要 |
FIELD: medicine, pharmaceutics. ^ SUBSTANCE: invention refers to oncology, namely to agents for cancer treatment. The combination contains N-(3-methoxy-6-methylpyrazine-2-yl)-2-(4 -[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3-sulfonamide and taxane or its derivatives, namely paclitaxel, docetaxel. The pharmaceutical composition contains such combinations in combination with one or more pharmaceutically acceptable diluents. Application of the combination for preparing the drug and treating or preventing cancer. ^ EFFECT: use of the combinations, the pharmaceutical composition allows providing higher clinical effectiveness. ^ 12 cl, 6 ex, 3 dwg |
